Dar es Salaam. A large-scale HIV vaccine trial conducted across Eastern and Southern Africa from 2020 to 2024 has concluded without success.
The PrEPVacc trial, which included sites in Tanzania, Uganda and South Africa, failed to demonstrate that either of the two experimental vaccine…
[ad_2]
Source link
